As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Thermo Fisher Scientific: Marex Group plc, Hudson Bay Capital Management LP, Man Group plc, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Volterra Technologies LP, Squarepoint Ops LLC, Alphadyne Asset Management LP, Qube Research & Technologies Ltd, Maven Securities LTD, Capula Management Ltd, Marshall Wace LLP, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Hsbc Holdings PLC, Capital Fund Management S.A., Jefferies Financial Group Inc., Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., SG Americas Securities LLC, Calamos Advisors LLC, Wolverine Asset Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, Baader Bank Aktiengesellschaft, and Quaker Wealth Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.